The company has received tentative approval from the United States
Food and Drug Administration (USFDA) to market the capsules in the
strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and
61.25 mg/245 mg, Zydus Cadila said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-tentative-nod-from-usfda-to-market-parkinsons-disease-drug/articleshow/77299625.cms
No comments:
Post a Comment